Publications by authors named "Eric C Ko"

Claim this Profile
N
Narrative review of stereotactic body radiation therapy combined with tyrosine kinase inhibitors for oligometastatic -mutated non-small cell lung cancer: present and future developments.
Xinchen Zhao, Shengwei Zhang, Xiaoyue Sun, Yao Lin, Luca Capone, Eric C Ko

Transl Lung Cancer Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for head and neck cancer: where do we go from here?
Eric C Ko, Glenn J Hanna

Immunotherapy· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitive Radiation Therapy for Medically Inoperable Endometrial Carcinoma.
James L Shen, Kevin W O'Connor, Janaki Moni, Susan Zweizig, Thomas J Fitzgerald, Eric C Ko

Adv Radiat Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiation therapy for metastatic non-small cell lung cancer: a versatile treatment, repurposed.
James L Shen, Eric C Ko

J Thorac Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy and Immunotherapy Combinations for Lung Cancer.
Vishesh Agrawal, Kimberly Thomas Benjamin, Eric C Ko

Curr Oncol Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Pathologic Complete Response 10 Weeks After Radiotherapy-A Radiobiological Sin.
Eric C Ko, Claire Vanpouille-Box, Silvia C Formenti

JAMA Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality.
Eric C Ko, Silvia C Formenti

Int J Radiat Biol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation unlocks the therapeutic potential of immune checkpoint blockers in lung cancer patients.
Eric C Ko, Lorenzo Galluzzi

Oncoimmunology· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Integration of Radiotherapy with Immunotherapy for the Treatment of Non-Small Cell Lung Cancer.
Eric C Ko, David Raben, Silvia C Formenti

Clin Cancer Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation.
Eric C Ko, Kimberly Thomas Benjamin, Silvia C Formenti

Adv Radiat Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy and checkpoint inhibitors: a winning new combination?
Eric C Ko, Silvia C Formenti

Ther Adv Med Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinically Nonmetastatic Prostate Cancer After Radical Prostatectomy.
Richard K Valicenti, Stephanie L Pugh, Edouard J Trabulsi, Oliver Sartor, Eric C Ko

Int J Radiat Oncol Biol Phys· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment strategies in low-volume metastatic castration-resistant prostate cancer.
Xiao X Wei, Eric C Ko, Charles J Ryan

Curr Opin Urol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative Radiation After Radical Prostatectomy.
Eric C Ko, Anthony L Michaud, Richard K Valicenti

Semin Radiat Oncol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy.
Hui-Ming Chen, Ge Ma, Neil Gildener-Leapman, Samuel Eisenstein, Brian A Coakley, Junko Ozao, Eric C Ko

Clin Cancer Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability, toxicity, and temporal implications of transoral robotic surgery (TORS) on adjuvant radiation therapy in carcinoma of the head and neck.
Todd J Carpenter, Benjamin Kann, Michael H Buckstein, Eric C Ko, Richard L Bakst

Ann Otol Rhinol Laryngol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of head and neck squamous cell cancer among HIV-infected patients.
Gypsyamber Dʼsouza, Thomas E Carey, William N William, Minh Ly Nguyen, Eric C Ko

J Acquir Immune Defic Syndr· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of early PSA failure time with increased distant metastasis and decreased survival in prostate brachytherapy patients.
Eric C Ko, Jerry T Liu, Nelson N Stone, Richard G Stock

Radiother Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases.
Charles C L Tong, Eric C Ko, Max W Sung, Jamie A Cesaretti, Richard G Stock, Junko Ozao-Choy

PLoS One· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
γ-H2AX kinetics as a novel approach to high content screening for small molecule radiosensitizers.
Shibo Fu, Ying Yang, Tirtha K Das, Yun Yen, Bing-sen Zhou, Eric C Ko

PLoS One· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure.
Eric C Ko, Nelson N Stone, Richard G Stock

Int J Radiat Oncol Biol Phys· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy.
Charles C L Tong, K H Vincent Lau, Michael Rivera, David Cannan, Julio Aguirre-Ghiso, Andrew G Sikora, Eric C Ko

Oncol Rep· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation.
Eric C Ko, Eric M Genden, Krzysztof Misiukiewicz, Peter M Som, Lale Kostakoglu

Oncol Rep· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 as a Novel Approach to Enhance Radiotherapy.
Shibo Fu, Michael Rivera, Eric C Ko, Andrew G Sikora, Chien-Ting Chen

J Cell Sci Ther· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting immune suppressing myeloid-derived suppressor cells in oncology.
Johnny Kao, Eric C Ko, Samuel Eisenstein, Andrew G Sikora, Shibo Fu

Crit Rev Oncol Hematol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis